Google's former engineering boss outlined 4 'radical' steps for keeping AI bias in check

Charlie Wood | Douglas Merrill's company has partnerships with firms like Microsoft to bring greater transparency to AI models.

Read More »

The biggest US health insurer and a top private-equity firm are likely buyers for $1.6 billion Magellan Health, according to Leerink

Clarrie Feinstein | Magellan Health is likely to be acquired for about $85 to $90 a share, according to Ana Gupte at SVB Leerink. A deal could come within a month.

Read More »

This CEO explains how his hot cybersecurity startup went from having 'several near death experiences' to raising $100 million

Rosalie Chan | Cybersecurity startup Vectra just closed $100 million in series E funding. CEO Hitesh Sheth explains his future plans for growing the company.

Read More »

A Goldman Sachs exec explains why the bank isn't sweating concerns over the Apple Card's profitability

Alex Morrell,Dakin Campbell | Credit-card competitors have cast doubt on the Apple Card's profit potential. Goldman's Omer Ismail sees the card as a tool to build customer loyalty.

Read More »

JPMorgan spends $11 billion on technology. But a top exec at the giant bank says some clients don't want it to be a tech company.

Bradley Saacks | At Business Insider's IGNITION conference, JPMorgan's head of digital banking Huw Richards said in less five years, the bank's tech insight will be a core offering.

Read More »

Here are the 10 fastest-growing cloud software apps of 2019 so far, according to the startup that connects them all

Rosalie Chan | These include apps for specific niches like real estate, marketing, and freelancing, as well as apps from tech giants like Facebook and Google.

Read More »

The innovation heads at Barclays and Morgan Stanley break down how their firms leverage technology to stay one step ahead of the competitors trying to steal their business

Dan DeFrancesco | Morgan Stanley's Megan Brewer and Barclay's Mariquit Corcoran detail how they encourage employees to create within their banks.

Read More »

Drug giant Merck just bought a biotech for $773 million, and it reveals the company's strategy for keeping on top in cancer treatments

Emma Court | Merck's top drug, Keytruda, is a $7 billion powerhouse that could soon bring in more than $20 billion.

Read More »

Goldman Sachs is sending much less mail to potential Marcus customers. A senior exec lays out the reason why.

Dakin Campbell | Omer Ismail explains why direct mail — a cornerstone of the consumer-loan industry — has become a smaller part of its strategy to get new customers.

Read More »